Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 49,500
-2,000 (-3.88%)
Apr 29, 2026, 3:30 PM KST
Hanall Biopharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 24,743 | 16,386 | 33,723 | 16,841 | 12,794 | Upgrade
|
| Short-Term Investments | - | - | - | 10,000 | - | Upgrade
|
| Trading Asset Securities | - | 8,320 | 22,775 | 27,093 | 67,775 | Upgrade
|
| Cash & Short-Term Investments | 24,743 | 24,706 | 56,497 | 53,934 | 80,570 | Upgrade
|
| Cash Growth | 0.15% | -56.27% | 4.75% | -33.06% | -11.18% | Upgrade
|
| Accounts Receivable | 16,869 | 15,335 | 15,630 | 26,689 | 9,861 | Upgrade
|
| Other Receivables | 2,385 | 4,735 | 6,894 | 4,021 | 5,694 | Upgrade
|
| Receivables | 19,354 | 20,069 | 22,524 | 30,709 | 15,555 | Upgrade
|
| Inventory | 38,112 | 37,702 | 32,384 | 25,184 | 20,408 | Upgrade
|
| Prepaid Expenses | 121.05 | 106.93 | 93.41 | 126.5 | 141.46 | Upgrade
|
| Other Current Assets | 2,582 | 2,769 | 2,078 | 1,835 | 2,141 | Upgrade
|
| Total Current Assets | 84,913 | 85,353 | 113,577 | 111,789 | 118,815 | Upgrade
|
| Property, Plant & Equipment | 17,092 | 18,517 | 19,434 | 19,126 | 19,045 | Upgrade
|
| Long-Term Investments | 44,017 | 44,134 | 59,626 | 39,315 | 23,990 | Upgrade
|
| Other Intangible Assets | 4,468 | 4,537 | 1,826 | 2,063 | 2,219 | Upgrade
|
| Long-Term Accounts Receivable | -0 | - | - | 0 | -0 | Upgrade
|
| Long-Term Deferred Tax Assets | 9,687 | 9,469 | 6,978 | 8,549 | 12,220 | Upgrade
|
| Long-Term Deferred Charges | 60,109 | 47,274 | 30,783 | 21,776 | 16,877 | Upgrade
|
| Other Long-Term Assets | 4,939 | 3,292 | 7,512 | 10,833 | 5,312 | Upgrade
|
| Total Assets | 225,224 | 212,881 | 239,747 | 213,451 | 198,478 | Upgrade
|
| Accounts Payable | 5,140 | 10,679 | 11,273 | 4,755 | 1,759 | Upgrade
|
| Accrued Expenses | 2,677 | 2,297 | 3,039 | 2,123 | 2,147 | Upgrade
|
| Short-Term Debt | 15,740 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 590.96 | 748.15 | 700.22 | 559.34 | 423.43 | Upgrade
|
| Current Income Taxes Payable | - | - | 356.7 | 919.83 | 94.87 | Upgrade
|
| Other Current Liabilities | 20,320 | 20,996 | 22,284 | 20,178 | 17,695 | Upgrade
|
| Total Current Liabilities | 44,468 | 34,720 | 37,652 | 28,535 | 22,120 | Upgrade
|
| Long-Term Debt | 15,000 | - | - | - | - | Upgrade
|
| Long-Term Leases | 586.33 | 699.66 | 590.31 | 751.06 | 911.68 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 403.86 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3,489 | 8,705 | 15,286 | 15,909 | 11,954 | Upgrade
|
| Total Liabilities | 63,543 | 44,529 | 53,529 | 45,195 | 34,986 | Upgrade
|
| Common Stock | 26,120 | 26,120 | 26,120 | 26,120 | 26,120 | Upgrade
|
| Additional Paid-In Capital | 120,461 | 116,768 | 115,040 | 112,800 | 112,777 | Upgrade
|
| Retained Earnings | 21,123 | 26,492 | 31,362 | 29,409 | 26,379 | Upgrade
|
| Treasury Stock | -14,659 | -12,587 | -13,205 | -13,228 | -3,254 | Upgrade
|
| Comprehensive Income & Other | 8,637 | 11,558 | 26,902 | 13,156 | 1,469 | Upgrade
|
| Shareholders' Equity | 161,681 | 168,351 | 186,218 | 168,256 | 163,492 | Upgrade
|
| Total Liabilities & Equity | 225,224 | 212,881 | 239,747 | 213,451 | 198,478 | Upgrade
|
| Total Debt | 31,917 | 1,448 | 1,291 | 1,310 | 1,335 | Upgrade
|
| Net Cash (Debt) | -7,174 | 23,259 | 55,207 | 52,624 | 79,234 | Upgrade
|
| Net Cash Growth | - | -57.87% | 4.91% | -33.59% | -12.11% | Upgrade
|
| Net Cash Per Share | -141.28 | 458.63 | 1089.06 | 1035.58 | 1547.46 | Upgrade
|
| Filing Date Shares Outstanding | 50.78 | 50.77 | 50.69 | 50.69 | 51.21 | Upgrade
|
| Total Common Shares Outstanding | 50.78 | 50.77 | 50.69 | 50.69 | 51.21 | Upgrade
|
| Working Capital | 40,445 | 50,633 | 75,925 | 83,254 | 96,695 | Upgrade
|
| Book Value Per Share | 3183.90 | 3316.25 | 3673.44 | 3319.29 | 3192.82 | Upgrade
|
| Tangible Book Value | 157,214 | 163,815 | 184,392 | 166,193 | 161,273 | Upgrade
|
| Tangible Book Value Per Share | 3095.93 | 3226.89 | 3637.42 | 3278.59 | 3149.48 | Upgrade
|
| Land | 1,494 | 1,494 | 1,494 | 1,494 | 1,494 | Upgrade
|
| Buildings | 17,862 | 17,467 | 17,417 | 17,363 | 14,968 | Upgrade
|
| Machinery | 13,924 | 14,021 | 16,638 | 16,546 | 14,294 | Upgrade
|
| Construction In Progress | - | 235.96 | 514.54 | 101.28 | 3,603 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.